A Resistance-Evading Antibiotic for Treating Anthrax

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Antimicrobial resistance (AMR) is a global health crisis causing millions of deaths.
• Engineered bioweapons, such as anthrax, pose a significant threat not addressed by current antibiotics.
• Novel antibiotics are crucial for combating AMR and bioweapon threats.

Approach:

• Teixobactin, an antibiotic with no known resistance, was investigated for its efficacy against anthrax.
• Teixobactin targets immutable precursors of bacterial cell wall polymers.
• A rabbit model of inhalation anthrax was used to evaluate teixobactin treatment.

Key Points:

• Teixobactin treatment rapidly eliminated Bacillus anthracis in rabbits post-infection.
• Teixobactin normalized body temperature and prevented tissue damage in treated rabbits.
• Teixobactin forms an irreversible supramolecular structure on the bacterial membrane, contributing to its potency.

Conclusions:

• Teixobactin is highly effective against inhalation anthrax in a preclinical model.
• Antibiotics that evade resistance, like teixobactins, offer a dual solution for AMR and bioweapons.
• Teixobactin represents a promising therapeutic strategy against weaponized pathogens.